In a decision that could significantly affect the CBD industry, the FDA recently extended the age range for Epidiolex to include patients one and older. Previously, Epidiolex was only available to people aged two and up, and this decision means that more children will have access to the drug.
Additionally, the FDA approved the use of Epidiolex to treat seizures caused by tuberous sclerosis…
